GSK Sees Big Opportunity In OTC Diet Aids: Xenical Switch NDA Filed
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline filed an Rx-to-OTC switch application for Xenical (orlistat 60 mg) in June, the firm announced July 28